Rank | Title | Journal | Year | PubWeight™‹?› |
---|---|---|---|---|
1 | The metabolic profile of tumors depends on both the responsible genetic lesion and tissue type. | Cell Metab | 2012 | 3.81 |
2 | Dihydroartemisinin targets VEGFR2 via the NF-κB pathway in endothelial cells to inhibit angiogenesis. | Cancer Biol Ther | 2014 | 0.89 |